Fasiplon
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C13H15N5O2 |
Molar mass | 273.296g·mol−1 |
3D model (JSmol) | |
| |
| |
NY(what is this?)(verify) |
Fasiplon(RU 33203) is anonbenzodiazepineanxiolyticdrug from theimidazopyrimidinefamily of drugs.
Fasiplon binds strongly to benzodiazepine sites on theGABAAreceptorand has similaranxiolyticeffects in animals, but with lesssedativeormuscle relaxantaction.[1]It was developed by a team atRoussel Uclafin the 1990s[2]
References[edit]
- ^Tully WR, Gardner CR, Gillespie RJ, Westwood R (July 1991). "2-(oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors".Journal of Medicinal Chemistry.34(7): 2060–7.doi:10.1021/jm00111a021.PMID1648620.
- ^US Patent 5869481 Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
Retrieved from "https://en.wikipedia.org/w/index.php?title=Fasiplon&oldid=1135227643"
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields